Cargando…
New insights into the role of melatonin in diabetic cardiomyopathy
Diabetic cardiovascular complications and impaired cardiac function are considered to be the main causes of death in diabetic patients worldwide, especially patients with type 2 diabetes mellitus (T2DM). An increasing number of studies have shown that melatonin, as the main product secreted by the p...
Autores principales: | Huang, Keming, Luo, Xianling, Zhong, Yi, Deng, Li, Feng, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8929360/ https://www.ncbi.nlm.nih.gov/pubmed/35005848 http://dx.doi.org/10.1002/prp2.904 |
Ejemplares similares
-
Insights into SGLT2 inhibitor treatment of diabetic cardiomyopathy: focus on the mechanisms
por: Huang, Keming, et al.
Publicado: (2023) -
Melatonin: new insights on its therapeutic properties in diabetic complications
por: Pourhanifeh, Mohammad Hossein, et al.
Publicado: (2020) -
Gut microbiota: A new therapeutic target for diabetic cardiomyopathy
por: Yuan, Suxin, et al.
Publicado: (2022) -
Role of inflammation in diabetic cardiomyopathy
por: Ramesh, Pranav, et al.
Publicado: (2022) -
Insight of Melatonin: The Potential of Melatonin to Treat Bacteria-Induced Mastitis
por: Li, Hongyang, et al.
Publicado: (2022)